Secretary of Energy Rick Perry recognized LLNL chemist Bill McLean with a prestigious Secretary’s Achievement Award yesterday in recognition of “pioneering technical contributions that have led to significant advancements in science-based stockpile stewardship.”
Scientists have designed a conceptual spacecraft to deflect Earth-bound asteroids and evaluated whether it would be able to nudge a massive asteroid – which has a remote chance to hitting Earth in 2135 – off course.
In the next 30 years, there is a one-in-three chance that the Hayward fault will rupture with a 6.7 magnitude or higher earthquake, according to the United States Geologic Survey (USGS). Such an earthquake will cause widespread damage to structures, transportation and utilities, as well as economic and social disruption in the East Bay.
A research team from Lawrence Livermore National Laboratory, the University of California, Berkeley and the University of Rochester have provided the first experimental evidence for superionic conduction in water ice at planetary interior conditions, verifying a 30-year-old prediction.
The Department of Energy’s Advanced Manufacturing Office (AMO) today announced the funding of $1.87 million for seven new industry projects under an ongoing initiative designed to utilize DOE’s high-performance computing (HPC) resources and expertise to advance U.S. manufacturing and clean energy technologies.
The Department of Energy’s Office of Fossil Energy (FE) today announced the funding of $450,000 for the first two private-public partnerships under a brand-new initiative aimed at discovering, designing and scaling up production of novel materials for severe environments.
A Lawrence Livermore National Laboratory biomedical technology that can deliver vaccines and drugs inside the human body has been licensed for use in cancer treatments to a Michigan company.
Lawrence Livermore National Laboratory scientists and engineers have developed a “brain-on-a-chip” device that could be used to test and predict the effects of biological and chemical agents, disease, or pharmaceutical drugs on the brain over time without the need for human or animal subjects.
Description: Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and University of California San Francisco will combine vast data stores, supercomputing, and scientific expertise to reinvent the discovery process for cancer medicines.
Lawrence Livermore National Lab will be part of a multi-lab effort to apply high-performance computing to US-based industry’s discovery, design, and development of materials for severe environments under a new initiative announced by the Department of Energy (DOE) on Sept. 19.